Evaluation of the Palliative Prognostic Score (PaP) and Routinely Collected Clinical Data in Prognostication of Survival for Patients Referred to a Palliative Care Consultation Service in an Acute Care Hospital

Abstract

The PaP was successfully validated in a population with characteristics that extend beyond those of the population in which it was originally developed. This is the largest sample in which the PaP has been validated to date.

Prospective Comparison of Prognostic Scores in Palliative Care Cancer Populations

“…These two factors are incorporated into the PaP score, which was originally built for a cancer population (excluding hematological and kidney cancers) undergoing palliative care [19,20]. Other studies have since highlighted its efficacy in all cancer types and also in non-cancer populations [44, 45,48]. A further criticism is that the score requires a blood sample to be taken.…”

Survival prediction for advanced cancer patients in the real world: A comparison of the Palliative Prognostic Score, Delirium-Palliative Prognostic Score, Palliative Prognostic Index and modified Prognosis in Palliative Care Study predictor model

“…Potential interpretation is that modified PiPS-B requires a CRP result which is not always included in routine blood tests, while PaP and D-PaP scores require a full blood count for calculation. In the previous studies of prognostic tools [9][10][11][12]19], blood sampling was performed in all patients after consent for research purpose or many patients admitted to hospitals received blood tests as a part of routine practice. Blood test is however not always performed in palliative settings especially at home and inpatient hospices worldwide [16,18], the finding of this study indicates that prognostic tools requiring blood tests may have lower feasibility in usual clinical settings.…”

“…Both were presented in 1999 by independent research groups from Italy and Japan. The PaP score was initially developed in hospice care services [5,6], and subsequently validated with independent prospective cohorts of patients treated by hospital palliative care teams, in inpatient hospices/palliative care units, in acute care/oncology settings and on a paediatric ward [9][10][11][12][13][14][15]. The PPI was initially developed in a palliative care unit [7,8], and thereafter independently validated in hospital palliative care teams, home palliative care services and acute care hospitals [16][17][18][19].…”

Prognosis Prediction Models and their Clinical Utility in Palliative Care

“…Canada [51][52][53][54][55]. Glare and Virik prospectively recruited 100 consecutive patients referred to palliative medicine consultative services.…”